Literature DB >> 26725831

Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.

Adib Zendedel1,2, Iraj Ragerdi Kashani3, Maryam Azimzadeh4, Parichehr Pasbakhsh4, Negar Omidi5, Abolfazl Golestani6, Cordian Beyer1, Tim Clarner1.   

Abstract

Chronic demyelination and plaque formation in multiple sclerosis is accompanied by persisting astrogliosis, negatively influencing central nervous system recovery and remyelination. Triiodothyronin (T3) is thought to enhance remyelination in the adult brain by the induction of oligodendrocyte maturation. We investigated additional astrocyte-mediated mechanisms by which T3 might promote remyelination in chronically demyelinated lesions using the cuprizone mouse model. C57BL/6 mice were fed cuprizone for 12 weeks to induce lesions with an impaired remyelination capacity. While the expression of oligodenrocyte progenitor markers, i.e., platelet derived growth factor-α receptor was not affected by T3 administration, myelination status, myelin protein expression as well as total and adult oligodendrocyte numbers were markedly increased compared to cuprizone treated controls. In addition to these effects on oligodendrocyte numbers and function, astrogliosis but not microgliosis was ameliorated by T3 administration. Intermediate filament proteins vimentin and nestin as well as the extracellular matrix component tenascin C were significantly reduced after T3 exposure, indicating additional effects of T3 on astrocytes and astrogliosis. Our data clearly indicate that T3 promotes remyelination in chronic lesions by both enhancing oligodendrocyte maturation and attenuating astrogliosis.

Entities:  

Keywords:  Astrogliosis; Cuprizone; Demyelination; Multiple sclerosis; Triiodothyronine

Mesh:

Substances:

Year:  2016        PMID: 26725831     DOI: 10.1007/s11011-015-9781-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  36 in total

Review 1.  Thyroid hormone and astroglia: endocrine control of the neural environment.

Authors:  R S Dezonne; F R S Lima; A G Trentin; F C Gomes
Journal:  J Neuroendocrinol       Date:  2015-06       Impact factor: 3.627

2.  A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.

Authors:  Emily G Baxi; Jason T Schott; Amanda N Fairchild; Leslie A Kirby; Rabia Karani; Prech Uapinyoying; Carlos Pardo-Villamizar; Jeffrey R Rothstein; Dwight E Bergles; Peter A Calabresi
Journal:  Glia       Date:  2014-05-24       Impact factor: 7.452

Review 3.  Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.

Authors:  Laura Calzà; Mercedes Fernandez; Alessandro Giuliani; Giulia D'Intino; Stefania Pirondi; Sandra Sivilia; Michela Paradisi; Nadia Desordi; Luciana Giardino
Journal:  Brain Res Brain Res Rev       Date:  2005-01-26

4.  Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia.

Authors:  Adib Zendedel; Pardes Habib; Jon Dang; Leoni Lammerding; Stefanie Hoffmann; Cordian Beyer; Alexander Slowik
Journal:  J Neuroimmunol       Date:  2014-11-14       Impact factor: 3.478

5.  Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Authors:  Laura-Adela Harsan; Jérôme Steibel; Anita Zaremba; Arnaud Agin; Rémy Sapin; Patrick Poulet; Blandine Guignard; Nathalie Parizel; Daniel Grucker; Nelly Boehm; Robert H Miller; M Said Ghandour
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

6.  Fibroblast growth factor 4 is required but not sufficient for the astrocyte dedifferentiation.

Authors:  Guo-Dong Feng; Bao-Rong He; Fan Lu; Lin-Hong Liu; Lingling Zhang; Bo Chen; Zu-Ping He; Ding-Jun Hao; Hao Yang
Journal:  Mol Neurobiol       Date:  2014-02-09       Impact factor: 5.590

7.  Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.

Authors:  Norah Hibbits; Jun Yoshino; Tuan Q Le; Regina C Armstrong
Journal:  ASN Neuro       Date:  2012-10-30       Impact factor: 4.146

8.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 9.  The Role of Astrocytes in Multiple Sclerosis Progression.

Authors:  Jorge Correale; Mauricio F Farez
Journal:  Front Neurol       Date:  2015-08-18       Impact factor: 4.003

10.  Thyroid hormone treated astrocytes induce maturation of cerebral cortical neurons through modulation of proteoglycan levels.

Authors:  Rômulo S Dezonne; Joice Stipursky; Ana P B Araujo; Jader Nones; Mauro S G Pavão; Marimélia Porcionatto; Flávia C A Gomes
Journal:  Front Cell Neurosci       Date:  2013-08-12       Impact factor: 5.505

View more
  12 in total

Review 1.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

2.  Myelin repair stimulated by CNS-selective thyroid hormone action.

Authors:  Meredith D Hartley; Tania Banerji; Ian J Tagge; Lisa L Kirkemo; Priya Chaudhary; Evan Calkins; Danielle Galipeau; Mitra D Shokat; Margaret J DeBell; Shelby Van Leuven; Hannah Miller; Gail Marracci; Edvinas Pocius; Tapasree Banerji; Skylar J Ferrara; J Matthew Meinig; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  JCI Insight       Date:  2019-04-18

3.  Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease.

Authors:  Andréa V Maglione; Bruna P P do Nascimento; Miriam O Ribeiro; Talytha J L de Souza; Renata E C da Silva; Monica A Sato; Carlos A A Penatti; Luiz R G Britto; Janaina S de Souza; Rui M B Maciel; Rodrigo Rodrigues da Conceição; Roberto Laureano-Melo; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2022-08-11       Impact factor: 3.655

4.  Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination.

Authors:  Golaleh Noorzehi; Parichehr Pasbakhsh; Maryam Borhani-Haghighi; Iraj Ragerdi Kashani; Soheila Madadi; Fatemeh Tahmasebi; Saied Nekoonam; Maryam Azizi
Journal:  J Mol Histol       Date:  2018-08-24       Impact factor: 2.611

5.  Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.

Authors:  Anna Nellessen; Stella Nyamoya; Adib Zendedel; Alexander Slowik; Christoph Wruck; Cordian Beyer; Athanassios Fragoulis; Tim Clarner
Journal:  Metab Brain Dis       Date:  2019-09-16       Impact factor: 3.584

Review 6.  Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.

Authors:  Floriana De Angelis; Domenico Plantone; Jeremy Chataway
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

7.  Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction.

Authors:  Elham Shiri; Parichehr Pasbakhsh; Maryam Borhani-Haghighi; Zohreh Alizadeh; Saied Nekoonam; Sina Mojaverrostami; Vahid Pirhajati Mahabadi; Ali Mehdi; Kazem Zibara; Iraj Ragerdi Kashani
Journal:  Cell Mol Neurobiol       Date:  2020-06-27       Impact factor: 5.046

8.  Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis.

Authors:  Sina Mojaverrostami; Parichehr Pasbakhsh; Soheila Madadi; Saeid Nekoonam; Davood Zarini; Leila Noori; Elham Shiri; Mohamad Salama; Kazem Zibara; Iraj Ragerdi Kashani
Journal:  Metab Brain Dis       Date:  2020-07-07       Impact factor: 3.584

9.  Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.

Authors:  P Chaudhary; G H Marracci; E Calkins; E Pocius; A L Bensen; T S Scanlan; B Emery; D N Bourdette
Journal:  J Neuroimmunol       Date:  2020-12-27       Impact factor: 3.478

10.  Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.

Authors:  Marwan Chami; Ramona Halmer; Laura Schnoeder; Katrin Anne Becker; Carola Meier; Klaus Fassbender; Erich Gulbins; Silke Walter
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.